David J Whiteside
Overview
Explore the profile of David J Whiteside including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hughes L, Adams N, Rouse M, Naessens M, Shaw A, Murley A, et al.
Alzheimers Dement
. 2025 Feb;
:e14531.
PMID: 39968697
Introduction: We examined how abnormal prefrontal neurophysiology and changes in gamma-aminobutyric acid-ergic (GABAergic) neurotransmission contribute to behavioral impairments in disorders associated with frontotemporal lobar degeneration (FTLD). Methods: We recorded magnetoencephalography...
2.
Holland N, Savulich G, Jones P, Whiteside D, Street D, Swann P, et al.
Mov Disord
. 2024 Apr;
39(7):1166-1178.
PMID: 38671545
Background/objective: The corticobasal syndrome (CBS) is a complex asymmetric movement disorder, with cognitive impairment. Although commonly associated with the primary 4-repeat-tauopathy of corticobasal degeneration, clinicopathological correlation is poor, and a...
3.
Whiteside D, Holland N, Tsvetanov K, Mak E, Malpetti M, Savulich G, et al.
Nat Commun
. 2023 Dec;
14(1):8458.
PMID: 38114493
There is extensive synaptic loss from frontotemporal lobar degeneration, in preclinical models and human in vivo and post mortem studies. Understanding the consequences of synaptic loss for network function is...
4.
Azevedo T, Bethlehem R, Whiteside D, Swaddiwudhipong N, Rowe J, Lio P, et al.
Commun Med (Lond)
. 2023 Jul;
3(1):100.
PMID: 37474615
Background: Identifying prediagnostic neurodegenerative disease is a critical issue in neurodegenerative disease research, and Alzheimer's disease (AD) in particular, to identify populations suitable for preventive and early disease-modifying trials. Evidence...
5.
Whiteside D, Street D, Murley A, Jones P, Malpetti M, Ghosh B, et al.
Hum Brain Mapp
. 2023 Jun;
44(11):4239-4255.
PMID: 37269181
There is a pressing need to understand the factors that predict prognosis in progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS), with high heterogeneity over the poor average survival. We...
6.
Holland N, Jones P, Savulich G, Naessens M, Malpetti M, Whiteside D, et al.
Mov Disord
. 2023 May;
38(7):1316-1326.
PMID: 37171832
Background: Synaptic loss is characteristic of many neurodegenerative diseases; it occurs early and is strongly related to functional deficits. Objective: In this longitudinal observational study, we determine the rate at...
7.
Whiteside D, Malpetti M, Jones P, Ghosh B, Coyle-Gilchrist I, Van Swieten J, et al.
Alzheimers Dement
. 2022 Nov;
19(5):1947-1962.
PMID: 36377606
Introduction: We tested whether changes in functional networks predict cognitive decline and conversion from the presymptomatic prodrome to symptomatic disease in familial frontotemporal dementia (FTD). Methods: For hypothesis generation, 36...
8.
Malpetti M, Jones P, Cope T, Holland N, Naessens M, Rouse M, et al.
Ann Neurol
. 2022 Nov;
93(1):142-154.
PMID: 36321699
Objective: Synaptic loss is an early feature of neurodegenerative disease models, and is severe in post mortem clinical studies, including frontotemporal dementia. Positron emission tomography (PET) with radiotracers that bind...
9.
Swaddiwudhipong N, Whiteside D, Hezemans F, Street D, Rowe J, Rittman T
Alzheimers Dement
. 2022 Oct;
19(5):1752-1763.
PMID: 36223793
Introduction: The pathophysiological processes of neurodegenerative diseases begin years before diagnosis. However, pre-diagnostic changes in cognition and physical function are poorly understood, especially in sporadic neurodegenerative disease. Methods: UK Biobank...
10.
Whiteside D, Jones P, Ghosh B, Coyle-Gilchrist I, Gerhard A, Hu M, et al.
Neurobiol Aging
. 2021 Aug;
107:109-117.
PMID: 34419788
The clinical syndromes of Progressive Supranuclear Palsy (PSP) may be mediated by abnormal temporal dynamics of brain networks, due to the impact of atrophy, synapse loss and neurotransmitter deficits. We...